Lower concentrations of circulating irisin have been observed in patients with stable coronary disease and advanced atherosclerotic lesions [34], which has also been demonstrated through meta-analysis of patient observations between 2000 and 2017, where patients with coronary disease exhibited lower concentrations of irisin compared to healthy persons [35]. Here, FNDC5 is linked to coronary artery disorder.